Pioglitazone
- Product NDC
- 53002-2757
- 11-digit product format
- 530022757
- Labeler code
- 53002
- Product ID
- 53002-2757_4657b69e-34a5-4ee5-931a-894e6f74ebb3
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Pioglitazone
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- RPK Pharmaceuticals, Inc.
- Application
- ANDA077210
- Marketing category
- ANDA
- Marketing start
- 2015-05-22
- Marketing end
- 0000-00-00
- Substance
- PIOGLITAZONE HYDROCHLORIDE
- Active strength
- 45 mg/1
- Pharmacologic classes
- Peroxisome Proliferator-activated Receptor Activity [MoA],PPAR alpha [CS],PPAR gamma [CS],Thiazolidinedione [EPC],Thiazolidinediones [CS],Peroxisome Proliferator Receptor alpha Agonist [EPC],Peroxisome Proliferator Receptor gamma Agonist [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2021-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 53002-2757-3 | Pioglitazone | 30 in 1 BOTTLE | TABLET | 30 | | 3 |
| 53002-2757-9 | Pioglitazone | 90 in 1 BOTTLE | TABLET | 90 | | 3 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 53002-2757 | PIOGLITAZONE TABLET [RPK PHARMACEUTICALS, INC.] | 3 | Legacy NDC, 2 package rows | 20230609_3b4ee4b1-1048-4ab3-8997-6d05c05903a9.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 53002-2757-3 | 53002275703 | 30 TABLET in 1 BOTTLE (53002-2757-3) | 30 tablet | 2020-01-01 | 0000-00-00 | No | No | Current |
| 53002-2757-9 | 53002275709 | 90 TABLET in 1 BOTTLE (53002-2757-9) | 90 tablet | 2020-01-01 | 0000-00-00 | No | No | Current |